SCHEMBL2594864

SCHEMBL2594864

Cc1c(P(=S)(c2ccccc2)c2ccccc2)c2ccccc2n1CC=Cc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 18/20 1.00
CHRM2 P08172 2/20 0.53
CHRM4 P08173 2/20 0.53
CHRM5 P08912 2/20 0.53
ADRA2A P08913 2/20 0.53
CHRM1 P11229 2/20 0.53
ADRB3 P13945 2/20 0.53
ADRA2C P18825 2/20 0.53
CHRM3 P20309 2/20 0.53
S1PR1 P21453 2/20 0.53
FPR1 P21462 2/20 0.53
SLC6A2 P23975 2/20 0.53
HRH2 P25021 2/20 0.53
FPR3 P25089 2/20 0.53
HTR2A P28223 2/20 0.53
AGTR1 P30556 2/20 0.53
GPR183 P32249 2/20 0.53
OPRM1 P35372 2/20 0.53
APLNR P35414 2/20 0.53
OPRK1 P41145 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2594863 1.00 NPSR1 (1.00) NPSR1CHRM2CHRM4CHRM5ADRA2A
SCHEMBL2587268 0.77 NPSR1 (0.63) NPSR1CHRM2ADRA2ACHRM1SLC6A2
SCHEMBL2593998 0.77 NPSR1 (0.63) NPSR1
SCHEMBL2586743 0.74 NPSR1 (0.58) NPSR1SIGMAR1
SCHEMBL2595693 0.73 NPSR1 (1.00) NPSR1TSHR
SCHEMBL486245 0.70 NPSR1 (0.53) NPSR1SLC6A2TSHRLMNA
SCHEMBL27210133 0.66 NPSR1 (0.49) NPSR1TSHRLMNA
SCHEMBL29811275 0.66 NPSR1 (0.49) NPSR1TSHRLMNA
SCHEMBL16066062 0.62 NPSR1 (0.45) NPSR1TSHR
SCHEMBL16066061 0.62 NPSR1 (0.45) NPSR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed